Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer
Stopped Insufficient patient inclusion
Conditions
- Breast Cancer
- Sentinel Lymph Node
Interventions
- DRUG: Tilmanocept
- DRUG: Nanocolloid
Sponsor
University Hospital, Ghent
Collaborators